Challenges and directions for Medicare ESRD payment policy

Area of Science:

• Health Economics
• Public Health Policy
• Renal Medicine

Background:

• Medicare's End-Stage Renal Disease (ESRD) program, established in 1973, faces ongoing challenges in balancing high-quality care access with payment containment.
• Despite policy interventions like controlling outpatient dialysis spending and risk shifting to private payers, ESRD program payments continue to outpace overall Medicare spending.
• Concerns exist among stakeholders that current policies may negatively impact the quality of care for ESRD beneficiaries.

Purpose of the Study:

• To analyze the financial trajectory and policy challenges within the Medicare ESRD program.
• To evaluate the effectiveness of past and present policies in controlling ESRD program expenditures.
• To explore potential strategies for mitigating future ESRD program spending growth.

Main Methods:

• Analysis of Medicare payment data and policy implementation since the ESRD program's inception.
• Review of stakeholder perspectives on care quality and access.
• Examination of the relationship between payment policies and program spending trends.

Main Results:

• Annual ESRD program payments have consistently grown faster than overall Medicare spending.
• Implemented policies have not effectively curbed the escalating costs of the ESRD program.
• Stakeholder concerns suggest potential adverse effects on beneficiary care quality.

Conclusions:

• Short-term relief for ESRD program spending may be achieved through refining payment systems within traditional Medicare and managed care.
• Long-term control of ESRD program spending necessitates fundamental changes in healthcare service delivery for this population.
• The current payment and delivery models require significant reform to ensure both cost-effectiveness and high-quality care for ESRD patients.